anthralin has been researched along with Skin Neoplasms in 30 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inflammatory linear verrucous epidermal nevus (ILVEN) is a rare and chronic skin disorder, which may trouble the patient considerably." | 2.67 | Treatment of inflammatory linear verrucous epidermal nevus. ( Rulo, HF; van de Kerkhof, PC, 1991) |
| "Anthralin was first synthesized in 1916." | 2.36 | Anthralin: historical and current perspectives. ( Andre, P; Ashton, RE; Lowe, NJ; Whitefield, M, 1983) |
| "Stubborn and extensive dermatoses, such as psoriasis vulgaris or atopic dermatitis (eczema), are indications for phototherapeutic methods." | 1.32 | [Phototherapy and photochemotherapy of inflammatory dermatoses]. ( Kerscher, M; Peter, RU; Pillekamp, H; Schiener, R, 2003) |
| " Although dose-response comparisons indicated that chrysarobin was several orders of magnitude less potent than TPA for promoting papilloma formation, this anthrone was 1." | 1.27 | Mechanism of mouse skin tumor promotion by chrysarobin. ( Aalfs, KK; Cantor, J; Coombs, MM; Decina, PC; DiGiovanni, J; Prichett, WP, 1985) |
| " However, dose-response studies with respect to DMBA in the two strains in two-stage carcinogenesis suggested that metabolic activation of DMBA to the active carcinogen was not limiting in the resistant strain." | 1.26 | Two-stage skin carcinogenesis in sensitive and resistant mouse strains. ( Ashman, LK; Cook, MG; Kotlarski, I; Murray, AW, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (63.33) | 18.7374 |
| 1990's | 8 (26.67) | 18.2507 |
| 2000's | 3 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Duuren, BL | 1 |
| Segal, A | 1 |
| Tseng, SS | 1 |
| Rusch, GM | 1 |
| Loewengart, G | 1 |
| Maté, U | 1 |
| Roth, D | 1 |
| Smith, A | 1 |
| Melchionne, S | 1 |
| Seidman, I | 1 |
| Schiener, R | 1 |
| Pillekamp, H | 1 |
| Kerscher, M | 1 |
| Peter, RU | 1 |
| Rundhaug, JE | 1 |
| Pavone, A | 1 |
| Kim, E | 1 |
| Fischer, SM | 2 |
| Ashton, RE | 1 |
| Andre, P | 1 |
| Lowe, NJ | 1 |
| Whitefield, M | 1 |
| Gensler, H | 1 |
| Bowden, GT | 1 |
| Männistö, PT | 2 |
| Vaissi, L | 1 |
| Mustakallio, KK | 1 |
| Viluksela, M | 2 |
| Kosma, VM | 2 |
| Collan, Y | 2 |
| Ashman, LK | 1 |
| Murray, AW | 1 |
| Cook, MG | 1 |
| Kotlarski, I | 1 |
| Dimitrova, I | 1 |
| Kostova, M | 1 |
| Mitrova, Z | 1 |
| Boutwell, RK | 1 |
| Hoel, MJ | 1 |
| Digiovanni, J | 3 |
| Briffa, DV | 1 |
| De Young, LM | 1 |
| Helmes, CT | 2 |
| Chao, WR | 2 |
| Young, JM | 1 |
| Miller, V | 1 |
| Yamamoto, S | 1 |
| Jiang, H | 1 |
| Kato, R | 1 |
| Phillips, DH | 1 |
| Alldrick, AJ | 1 |
| La, E | 1 |
| Muga, SJ | 1 |
| Locniskar, MF | 1 |
| Messer, G | 1 |
| Rupec, RA | 1 |
| Driedger, PE | 1 |
| Blumberg, PM | 1 |
| Zackheim, HS | 1 |
| Baxter, CS | 1 |
| Andringa, A | 1 |
| Chalfin, K | 1 |
| Miller, ML | 1 |
| Merk, HF | 1 |
| Jugert, FK | 1 |
| Rulo, HF | 1 |
| van de Kerkhof, PC | 2 |
| Tabara, M | 1 |
| Watanabe, M | 1 |
| de Mare, S | 1 |
| Happle, R | 1 |
| Marks, F | 1 |
| Fürstenberger, G | 1 |
| Naukkarinen, A | 1 |
| Aalto, ML | 1 |
| Männistö, P | 1 |
| Kruszewski, FH | 1 |
| Coombs, MM | 2 |
| Bhatt, TS | 1 |
| Pezeshk, A | 1 |
| Yuspa, SH | 1 |
| Dawson, MI | 1 |
| Puotunen, E | 1 |
| Newman, AJ | 1 |
| Goerz, G | 1 |
| Merk, H | 1 |
| Hölzle, E | 1 |
| Decina, PC | 1 |
| Prichett, WP | 1 |
| Cantor, J | 1 |
| Aalfs, KK | 1 |
3 reviews available for anthralin and Skin Neoplasms
| Article | Year |
|---|---|
Anthralin: historical and current perspectives.
Topics: Anthracenes; Anthralin; Cell Division; Chemistry; Cyclic AMP; Cyclic GMP; DNA Replication; Drug Admi | 1983 |
Cutaneous NAD(P)H: quinone reductase: a xenobiotica-metabolizing enzyme with potential cancer and oxidation stress-protecting properties.
Topics: Animals; Anthralin; Humans; Oxidation-Reduction; Quinone Reductases; Skin; Skin Neoplasms; Xenobioti | 1991 |
Cutaneous chemical carcinogenesis.
Topics: Animals; Anthralin; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; DNA; Enzym | 1986 |
1 trial available for anthralin and Skin Neoplasms
| Article | Year |
|---|---|
Treatment of inflammatory linear verrucous epidermal nevus.
Topics: Adolescent; Anthralin; Female; Humans; Inflammation; Isotretinoin; Nevus; Skin Neoplasms | 1991 |
26 other studies available for anthralin and Skin Neoplasms
| Article | Year |
|---|---|
Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
Topics: Animals; Anthracenes; Anthralin; Anthraquinones; Chemical Phenomena; Chemistry; Female; Metals; Mice | 1978 |
[Phototherapy and photochemotherapy of inflammatory dermatoses].
Topics: Administration, Topical; Adolescent; Anthralin; Anti-Inflammatory Agents; Child; Combined Modality T | 2003 |
The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthralin; Blotting, Northern; Blotting, Western; Carcino | 2007 |
Influence of 13-cis-retinoic acid on mouse skin tumor initiation and promotion.
Topics: Animals; Anthralin; Benzo(a)pyrene; Benzopyrenes; Female; Isotretinoin; Methylnitronitrosoguanidine; | 1984 |
Tumor-producing activity of dithranol (anthralin) and two of its 10-acyl analogs in the dorsal skin of female NMRI mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Anthracenes; Anthralin; Body Wei | 1984 |
Two-stage skin carcinogenesis in sensitive and resistant mouse strains.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthralin; Dose-Response Relationship, Drug; Female; Mice | 1982 |
[Linear psoriasis?].
Topics: Anthralin; Female; Humans; Middle Aged; Nevus, Pigmented; Psoriasis; Skin Neoplasms | 1983 |
The role of anthralin in mouse skin tumour promotion.
Topics: Animals; Anthracenes; Anthralin; DNA; Enzyme Induction; Mice; Neoplasms, Experimental; Ornithine Dec | 1981 |
Antipsoriatic therapy and skin cancer.
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Skin Neoplasms | 1981 |
Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.
Topics: Animals; Anthracenes; Anthralin; Carboxy-Lyases; Cell Division; Enzyme Induction; Epidermal Cells; E | 1981 |
Inhibition of anthralin-caused skin tumor promotion and interleukin-1 alpha production by potent immunosuppressant FK506.
Topics: Administration, Topical; Animals; Anthralin; Anticarcinogenic Agents; Carcinogens; Female; Interleuk | 1994 |
Tumorigenicity of a combination of psoriasis therapies.
Topics: Adenosine Triphosphate; Administration, Topical; Animals; Anthralin; Benzo(a)pyrene; Carcinogens; Co | 1994 |
Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthralin; Blotting, Northern; Blotting, Western; Carcino | 1999 |
[Nuclear factor kappa B (NF-kappa B). II. Pathophysiologic meaning].
Topics: Acute-Phase Reaction; Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Autoimm | 2001 |
Non-phorbol mouse skin tumor promoters do not mimic phorbol myristate acetate in its effects on chick embryo fibroblasts.
Topics: Acetates; Animals; Anthralin; Cantharidin; Carcinogens; Cell Membrane; Chick Embryo; Cytochalasin B; | 1978 |
Evaluation of anthralin for mycosis fungoides.
Topics: Adult; Aged; Anthralin; Erythema; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Ointments; S | 1992 |
Effect of tumor-promoting agents on density and morphometric parameters of mouse epidermal Langerhans and Thy-1+ cells.
Topics: Alkanes; Animals; Anthralin; Antigens, Surface; Carcinogens; Cell Count; Dendritic Cells; Epidermis; | 1991 |
Suppression of footpad reaction in mice by anthralin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthralin; Erythrocytes; Hindlimb; Hypersensitivity, Dela | 1990 |
Dithranol in the treatment of inflammatory linear verrucous epidermal nevus.
Topics: Adult; Anthralin; Humans; Inflammation; Male; Nevus; Skin Neoplasms | 1989 |
Experimental evidence that skin carcinogenesis is a multistep phenomenon.
Topics: Animals; Anthralin; Benzoyl Peroxide; Iodoacetates; Iodoacetic Acid; Lyngbya Toxins; Mice; Neoplasm | 1986 |
Histopathological and morphometrical analysis applied to skin changes in NMRI mice induced by dithranol (anthranil) and its acyl analogs.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthralin; Cell Nucleus; DNA; Female; Hyperplasia; Mice; | 1986 |
Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones.
Topics: Animals; Anthracenes; Anthralin; Enzyme Induction; Female; Free Radicals; Mice; Ornithine Decarboxyl | 1988 |
Inhibition by retinoids of anthralin-induced mouse epidermal ornithine decarboxylase activity and anthralin-promoted skin tumor formation.
Topics: Administration, Topical; Animals; Anthralin; Chemical Phenomena; Chemistry; Enzyme Induction; Epider | 1987 |
Tumor-producing and skin-irritating activity of dithranol (anthralin) and its 10-acyl analogues in SENCAR mice.
Topics: Animals; Anthralin; Blood; Body Weight; Female; Irritants; Male; Mice; Neoplasms, Experimental; Orga | 1986 |
[Tar treatment of psoriasis].
Topics: Anthralin; Combined Modality Therapy; Drug Therapy, Combination; Humans; Psoriasis; Radiotherapy Dos | 1985 |
Mechanism of mouse skin tumor promotion by chrysarobin.
Topics: Animals; Anthracenes; Anthralin; Carcinogens; Dose-Response Relationship, Drug; Edema; Female; Hyper | 1985 |